These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20539176)

  • 1. Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1.
    Raoof M; Zhang Q; Itagaki K; Hauser CJ
    J Trauma; 2010 Jun; 68(6):1328-32; discussion 1332-4. PubMed ID: 20539176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
    Rabiet MJ; Huet E; Boulay F
    Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
    Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
    J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1.
    Svensson L; Redvall E; Björn C; Karlsson J; Bergin AM; Rabiet MJ; Dahlgren C; Wennerås C
    Eur J Immunol; 2007 Jul; 37(7):1966-77. PubMed ID: 17559171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
    Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
    Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
    Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
    Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.
    Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM
    J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial damage-associated molecular patterns from fractures suppress pulmonary immune responses via formyl peptide receptors 1 and 2.
    Li H; Itagaki K; Sandler N; Gallo D; Galenkamp A; Kaczmarek E; Livingston DH; Zeng Y; Lee YT; Tang IT; Isal B; Otterbein L; Hauser CJ
    J Trauma Acute Care Surg; 2015 Feb; 78(2):272-9; discussion 279-81. PubMed ID: 25757111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Quinn MT
    Mol Pharmacol; 2007 Apr; 71(4):1061-74. PubMed ID: 17229869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
    Karlsson J; Fu H; Boulay F; Dahlgren C; Hellstrand K; Movitz C
    J Leukoc Biol; 2005 Sep; 78(3):762-71. PubMed ID: 15951351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
    Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
    Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor.
    Lee HY; Bae YS
    Biochem Biophys Res Commun; 2008 May; 369(2):573-8. PubMed ID: 18294454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR.
    Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP
    J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of five human mitochondrial formyl peptides mimics bacterial peptides and functionally deactivates human neutrophils.
    Kaczmarek E; Hauser CJ; Kwon WY; Riça I; Chen L; Sandler N; Otterbein LE; Campbell Y; Cook CH; Yaffe MB; Marusich MF; Itagaki K
    J Trauma Acute Care Surg; 2018 Nov; 85(5):936-943. PubMed ID: 29787548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils.
    Svensson L; Redvall E; Johnsson M; Stenfeldt AL; Dahlgren C; Wennerås C
    J Leukoc Biol; 2009 Aug; 86(2):327-36. PubMed ID: 19414538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitocryptide-2: purification, identification, and characterization of a novel cryptide that activates neutrophils.
    Mukai H; Seki T; Nakano H; Hokari Y; Takao T; Kawanami M; Tsukagoshi H; Kimura H; Kiso Y; Shimonishi Y; Nishi Y; Munekata E
    J Immunol; 2009 Apr; 182(8):5072-80. PubMed ID: 19342687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic devices for characterizing the agonist of formyl peptide receptor in RBL-FPR cells.
    Ye N; Wang MW; Qin J; Lin B
    Biomed Microdevices; 2010 Jun; 12(3):513-21. PubMed ID: 20195765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the ratio between FPR and FPRL1 triggered superoxide production in human neutrophils-a tool in analysing receptor specific events.
    Fu H; Karlsson J; Björkman L; Stenfeldt AL; Karlsson A; Bylund J; Dahlgren C
    J Immunol Methods; 2008 Feb; 331(1-2):50-8. PubMed ID: 18166194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.